Currently out of the existing stock ratings of Aaron Gal, 17 are a HOLD (43.59%), 22 are a BUY (56.41%).

Aaron Gal

Work Performance Price Targets & Ratings Chart

Analyst Aaron Gal, carries an average stock price target met ratio of 62.98% that have a potential upside of 20.87% achieved within 297 days. Previously, Aaron Gal worked at BERNSTEIN.

Aaron Gal’s has documented 78 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 16-Oct-2024.

Wall Street Analyst Aaron Gal

Analyst best performing recommendations are on PFE (PFIZER).
The best stock recommendation documented was for PFE (PFIZER) at 11/2/2021. The price target of $44 was fulfilled within 3 days with a profit of $2.26 (5.41%) receiving and performance score of 18.05.

Average potential price target upside

of $103.71 (20.19%) on REGN (REGENERON PHARMACEUTICALS).
of $46.9 (43.14%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $33.55 (11.32%) on BIIB (BIOGEN).

BIIB Biogen PFE Pfizer REGN Regeneron Pharmaceuticals ABBV AbbVie GILD Gilead Sciences VTRS Viatris JAZZ Jazz Pharmaceuticals PLC TEVA Teva Pharma Industries Ltd ADR AMGN Amgen AGN Allergan plc MNTA Momenta Pharmaceuticals MYL Viatris

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matthew Harrison (MORGAN STANLEY)